BioProcess Blog
Upcoming Events

©Copyright 2010 BioProcess Technology Consultants, Inc.
Purification column photo courtesy of Wacker Biotech GmbH.
We've moved -- new address and phones
BioProcess Technology Consultants header image
    About Us Services Experience Our Team Information BioProcess Blog Contact Us Home
BioProcess Technology Consultants
News

The Development of Therapeutic Monoclonal Antibody Products by BioProcess Technology Consultants New Special Report
The Development of Therapeutic Monoclonal Antibody Products
  Three GxP Guides from BioProcess Technology Consultants Three GxP Guides
Good Laboratory Practices (GLP)
Good Manufacturing Practices (GMP)
Good Clinical Practices
(GCP)

Report
Special Reports
From Clone to Commercial
From Clone to Commercial
Biomanufacturing Supply and Demand Databases
Manufacturing Operations and Support
Biomanufacturing Supply and Demand Databases
Biopharmaceutical Manufacturing Operations and Support
Biopharmaceutical Business Strategy and Operational Excellence
Quotes See what our clients
say about us.
Randomly chosen quote image
Randomly chosen quote image

 

Spectrum
Business Strategy and
Operational Excellence
Due Diligence and
Technology/Market Analysis
Process and Product Development
Quality and Regulatory
Outsourcing and Supply Chain Management
Process and Product Development
Due Diligencs and Technology/Market Analysis
Quality and Regulatory
Outsourcing and Supply Chain Management
world-leading biopharmaceutical consulting team
BioProcess Technology Consultants is the world leader in providing strategic, technical, and regulatory consulting services to the biopharmaceutical industry. As experts in process and product development, manufacturing, quality, and regulatory affairs for biologic products, we assist and support clients in developing and implementing manufacturing strategies, operational excellence, and due diligence. We can help shorten your time to market and enhance your company's value as you navigate the technical and regulatory hurdles along the path from clone to commercial®. We have helped over 300 clients move their products from discovery into clinical development, and have supported the commercialization and launch of more than a dozen licensed biopharmaceutical products worldwide. Our clients include companies in the US, Canada, Europe, the Middle East, the Far East and Pacific Rim, South America, and India.